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Abstract
Lymphatic vessels play an essential role in intestinal lipid uptake, and impairment of lymphatic vessel function leads to
enhanced adipose tissue accumulation in patients with lymphedema and in genetic mouse models of lymphatic
dysfunction. However, the effects of obesity on lymphatic function have been poorly studied. We investigated if and how
adipose tissue accumulation influences lymphatic function. Using a lymphatic specific tracer, we performed in vivo near-
infrared (NIR) imaging to assess the function of collecting lymphatic vessels in mice fed normal chow or high-fat diet (HFD).
Histological and whole mount analyses were performed to investigate the morphological changes in initial and the
collecting lymphatic vessels. HFD was associated with impaired collecting lymphatic vessel function, as evidenced by
reduced frequency of contractions and diminished response to mechanostimulation. Moreover, we found a significant
negative correlation between collecting lymphatic vessel function and body weight. Whole mount analyses showed an
enlargement of contractile collecting lymphatic vessels of the hind limb. In K14-VEGF-C mice, HFD resulted in a reduced
spreading of the tracer within dermal lymphatic vessels. These findings indicate that adipose tissue expansion due to HFD
leads to a functional impairment of the lymphatic vasculature, predominantly in collecting lymphatic vessels.
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Introduction
The lymphatic system is essential in mediating tissue fluid
homeostasis, immune surveillance and uptake of dietary fat in the
intestine [1]. A number of observations indicate close interactions
between lymphatic vessels and adipose tissue [2]. Accumulation of
adipose tissue is regularly observed in the affected tissue of
lymphedema patients [3], there is a close association of lymph
nodes (LNs) and collecting lymphatic vessels with adipose tissue
throughout the body [4], and addition of lymph fluid to
preadipocytes in vitro promoted their differentiation into mature
adipocytes [5]. These observations are supported by findings in
genetic [5–7] and surgical [8] mouse models of lymphedema. Mice
haploinsufficient for Prox1, a master regulator of lymphatic
differentiation, develop chylous ascites and adult onset obesity
due to defective lymphatic vessels [5]. Moreover, in two mouse
models of primary lymphedema –Chy [7] and K14-VEGFR-3-Ig
mice [6]– an inverse correlation between dermal lipid accumu-
lation and hydraulic conductivity was found [9]. Conversely, it
remains unclear if obesity affects lymphatic function. In mice, it
was recently found that obesity diminishes lymphatic fluid
transport to draining lymph nodes [10]. However, in humans
the data are more controversial –while one study found
impairment of lymphatic function in morbidly obese patients
[11], another recent report found similar lymph flow between
normal weight and obese individuals [12].
We aimed to investigate if and how diet-induced obesity affects
the morphology and function of the lymphatic vasculature. To this
end, mice were fed a high-fat diet (HFD) and then we performed
morphometric assessments of lymphatic vessels and employed
high-resolution near infrared (NIR) imaging to quantitatively
investigate the function of collecting lymphatic vessels in the hind-
leg of mice in vivo. In three different mouse strains, we found that
HFD was associated with an impairment of collecting lymphatic
vessel function. These findings imply that lymphatic dysfunction
can be induced by adipose tissue expansion.
Materials and Methods
3.1 Animal models-Ethics statement
Male C57BL/6J:ICR mice (n = 20), FVB mice (n = 16) and
K14-VEGF-C mice [13] (n = 8) were kept under conventional SPF
conditions. For each strain, starting at 4 weeks of age, half of the
mice were provided ad libitum access to standard chow (chow; 11%
kcal from fat, 31% kcal from protein, and 58% kcal from
carbohydrate; Provimi-Kliba, Kaiseraugst, Switzerland), and the
other half to high-fat diet (HFD; 60% kcal from fat, 20% kcal from
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protein, and 20% kcal from carbohydrate; Research Diets Inc.,
New Brunswick, NJ, USA) for 17 weeks or 31 weeks. Mice were
anesthetized by i.p. injection of 0.2 mg/kg medetomidine and
80 mg/kg ketamine for imaging. Mice were sacrificed with an
overdose of anesthesia (1000 mg/kg ketamine/3.5 mg/kg mede-
tomidine) followed by cervical dislocation. All experiments were
performed in accordance with animal protocols approved by
Kantonales Veterinäramt Zürich.
3.2 Analysis of water content
Water content was analyzed as previously described [9]. Briefly,
back skin samples were collected with 6 mm biopsy punches
(Acuderm, Fort Lauderdale, FL, USA). The samples were weighed
after the collection and freeze-dried for 24 h. Thereafter, the
samples were weighed again, and the weight loss was calculated.
Since this procedure removed the water from the tissues, the
weight loss represented the water content of the tissue.
3.3 Histology and immunofluorescence analyses
Cryosections of the tails (7 mm) were fixed for 2 min in acetone
(–20uC) and for 5 min in 80% methanol (4uC), washed in PBS and
incubated overnight (4uC) with a hamster anti-podoplanin
antibody (clone 8.1.1, Developmental Studies Hybridoma Bank,
University of Iowa) and rat anti-Meca32 antibody (1:200, BD
Pharmingen, Allschwil), or rabbit anti-LYVE-1 (1:600, AngioBio)
and rat anti-CD31 (1:200, BD Pharmingen). The samples were
then incubated for 30 min with Alexa488- and Alexa594-
conjugated secondary antibodies (1:200) and Hoechst 33342
(1:1000; all from Invitrogen, Basel, Switzerland). Regular hema-
toxylin staining was used to stain paraffin sections (8 mm) of the
tail.
3.4 Morphometric and morphologic analyses
Immunofluorescence stains of tail skin sections for podoplanin-
positive lymphatic vessels and for Meca32-positive blood vessels
were examined on an Axioskop 2 mot plus microscope (Carl Zeiss,
Feldbach, Switzerland), and the images of 3 to 5 individual fields
of view per section were acquired with an AxioCam MRc camera
with a Plan-APOCHROMAT 106/0.45 NA objective and
AxioVision software 4.7.1 (Carl Zeiss, Feldbach, Switzerland).
The thickness of the epidermis, the dermis and the adipose tissue
was determined on hematoxylin-stained paraffin sections of tail
skin. The morphometric analyses of the vessels and of tissue
thickness were performed with ImageJ software [14].
3.5 Whole mount immunostaining
We harvested whole ears and the collecting lymphatic vessels
from the lower limb for whole mount analysis after 31 weeks of
either chow or HFD. Ears were split in half and the inner part of
the ear (without cartilage) was used. Evans blue (5 mL, 0.1%) was
injected intradermally to visualize the collecting lymphatic vessels
of the hind limb to aid in the dissection of the lower limb collecting
lymphatic vessels and the associated saphenous vein. The tissue
samples were immobilized using insect pins onto self-made silicon-
coated tissue culture plates. The tissues were then fixed with 4%
PFA in PBS for 2 h and blocked with immunomix (5% normal
donkey serum, 1% BSA, 0.1% Triton-X 100 and 0.05% NaN3) for
1 h. Rat-anti mouse CD31 (BD Pharmingen, 1:250 dilution) and
mouse-anti-mouse a-smooth muscle actin (Sigma, 1:1000 dilution,
conjugated to Cy3) were diluted in immunomix and the tissues
were incubated in the primary antibody mix overnight at 4uC.
After washing with PBS for 2 h, the samples were incubated with
an Alexa488 conjugated donkey-anti-rat IgG (Molecular probes,
1:200 dilution) for 2 h at room temperature. Thereafter, the
samples were washed with PBS for at least 2 h and mounted on
glass slides using Mowiol (Calbiochem). Confocal imaging was
performed on a Zeiss LSM 710-FCS confocal microscope
equipped with a 206 0.8 NA Plan-Apochromat objective (Carl
Zeiss). Z-stack images were acquired using Zeiss ZEN 2009
software and processed using ImageJ [14].
3.6 In vivo imaging of lymphatic vessel function
A Zeiss StereoLumar.V12 stereomicroscope adapted for NIR
visualization was used for lymphatic imaging [15]. Videos were
recorded during intradermal injection of the lymph-specific tracers
P20D680 or P40D680 into the foot [15]. Additional videos to
visualize the contractility of collecting lymphatic vessels draining
the lower limb were acquired before and after mechanostimulation
of the injection site. Mechanostimulation was performed using a
cotton swab pressed gently on the injection site once per second for
ten seconds to stimulate initial lymphatic uptake of the tracer and
demonstrate the capacity of the lymphatic system to react to a
sudden fluid load [15]. A region of interest (ROI) analysis of
fluorescence intensity was performed to assess the frequency of
collecting lymphatic vessel contractions. The response to mechan-
ostimulation was assessed by determining the fold-change in mean
fluorescence intensity during 30 s periods immediately before
mechanostimulation and starting from 30 s after mechanostimula-
tion.
3.7 Perfused skin area analysis
Two to three NIR images of the hind limb were combined
together to obtain an overview of the whole leg – including the
ankle and the distal third of the upper leg – using Photoshop
software v 5.0 (Adobe Systems). A rectangular ROI of 6 mm in
width and 15 mm in height was placed on the NIR picture, taking
the midpoint of the arc of the dorsal collecting lymphatic vessel as
a reference point, and the image was cropped. The total area of
the skin and the dye-perfused area within the cropped image were
then measured by manual selection using the polygonal lasso tool
of Photoshop software. The perfused area was then calculated as a
percentage of the total area of skin.
3.8 Statistical analyses
All data are shown as mean 6 SD. Means of groups were
compared using Student’s t-test; Welch’s correction was used in
case of unequal variances, and Mann-Whitney U test was used for
the comparisons of non-normally distributed data. P,0.05 was
accepted as statistically significant.
Results
4.1 Weight gain and adipose tissue enlargement after
HFD
HFD was initiated in male FVB and C57BL/6J:ICR mice at 4
weeks of age. After 17 weeks on HFD, the body weight was
significantly increased in both strains, as compared to the chow fed
group (FVB: HFD, 43.763.6 g vs. chow, 35.261.0 g (n = 8);
P = 0.0002; C57BL/6J:ICR: HFD, 56.564.8 g vs. chow,
44.565.7 g (n = 5); P = 0.0071; Figure 1A). The water content of
back skin was reduced after 17 weeks on HFD (FVB: HFD,
0.4160.11 mL/g vs. chow, 0.5360.10 mL/g; P = 0.0405;
C57BL/6J:ICR: HFD, 0.3460.06 mL/g vs. chow,
0.5360.06 mL/g; P = 0.0013; Figure 1B). A significant increase
of adipose tissue with hypertrophic adipocytes (Figure 1C and D)
was detected in the tails (subcutaneous layer thickness in HFD,
269.5618.4 mm vs. chow, 150.8615.9 mm; P,0.0001, Figure 1E).
Obesity Induces Lymphatic Dysfunction
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Figure 1. Reduced water content and increased adipose tissue after HFD. Significantly increased body weight (A) and reduced skin water
content in back skin (B) after 17 weeks of HFD. Hematoxylin stainings (C,D) and quantitative image analyses (E) revealed a significantly increased
thickness of the adipose tissue, but not of the epidermis or dermis, in the tail skin of C57BL/6J:ICR HFD mice. Immunofluorescence stains for
podoplanin (F,G; red; lymphatic vessels) and Meca32 (H,I; green; blood vessels) and quantitative image analyses (J) revealed a reduction of the
average dermal lymphatic vessel size, but not blood vessel size, after HFD. Scale bars = 100 mm. Data represent mean 6 SD. *P#0.05, **P#0.01,
***P#0.001.
doi:10.1371/journal.pone.0094713.g001
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4.2 Comparable initial lymphatic vessel density in skin
Immunofluorescence stains for blood vessels and lymphatic
vessels were done using antibodies against podoplanin and
Meca32. Morphometric analyses of blood vessels and lymphatic
vessels in the tail dermis revealed that the HFD fed mice had a
tendency towards reduced average dermal lymphatic vessel size
(151.0653.3 mm2) compared to chow fed mice
(240.26140.4 mm2; NS), whereas blood vessels remained unaf-
fected (HFD, 95.868.8 mm2 vs. chow, 99.9628.0; NS; Figure 1F-
J). This tendency was also observed when the tails were stained for
LYVE-1 and CD31 (Figure 1K and L).
4.3 Impaired collecting lymphatic vessel function in HFD
fed mice
We next assessed the collecting vessel function in the limb of the
mice using NIR imaging (Figure 2A). We first visualized and
Figure 2. Impaired collecting lymphatic vessel function after 17 weeks of HFD in FVB mice. NIR-imaging (A) was performed after
intradermal injection of 5 mL of 25 mM P20D680, a tracer specific for uptake into lymphatic vessels. Collecting lymphatic vessel contractility analysis
was performed on the afferent vessels near the popliteal LN, while the response to mechanostimulation of the injection site by a cotton swab was
assessed on the collecting lymphatic vessels of the lower limb. Normal (B) and irregular (C) contraction patterns in chow and HFD mice, respectively.
Linear regression analysis (D) shows a significant negative correlation between weight and contraction frequencies. Normal (E) and impaired
response (F) to mechanostimulation. Mice on HFD showed reduced response to mechanostimulation (G) as compared to mice on chow diet.
**P#0.01.
doi:10.1371/journal.pone.0094713.g002
Obesity Induces Lymphatic Dysfunction
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quantified the contraction frequency of the afferent collecting
lymphatic vessels near the entrance to popliteal LN. We also
determined the response to an acute fluid load – by mechan-
ostimulation – of the afferent collectors in the lower limb during
mechanostimulation to the injection site.
We found that contractility of collecting lymphatic vessels in the
hind legs of chow fed mice appeared normal, with contraction
frequencies of approximately 9 per minute (Figure 2B, Figure S1A
and Video S1). In contrast, the contractions of collecting
lymphatic vessels in HFD mice were without a definite pattern
(Figure 2C, Figure S1A and Video S2,) and contraction
frequencies were significantly reduced (chow: 9.061.7 contrac-
tions/min vs. HFD: 4.261.1 contractions/min, P = 0.0002).
There was a significant inverse correlation between the weight
of the mice and the contraction frequencies in both FVB
(r2 = 0.68, P = 0.001; Figure 2D) and C57BL/6J:ICR (r2 = 0.52,
P = 0.028; Figure S1A) strains.
We also found a reduced response to mechanostimulation in
mice on HFD. Normal mice displayed a typical pattern of an
immediate signal increase in the downstream collecting lymphatic
vessels during mechanostimulation of the injection site, followed
by a slow decrease in signal over time (Figure 2E). In contrast,
most mice on HFD had a reduced signal increase during
mechanostimulation and no apparent decrease in signal over time
(Figure 2F). We quantified this response using the fold-change in
mean fluorescence intensities of the collecting lymphatic vessels
from before to after mechanostimulation. Using this assessment,
we found a significant reduction in the increase of signal after
mechanostimulation in collecting lymphatic vessels under HFD in
both FVB (chow: 2.461.3 fold vs. HFD: 1.560.5 fold, P = 0.0079;
Figure 2G) and C57BL/6J:ICR mice (chow: 2.960.1 fold vs.
HFD: 1.260.2 fold, P = 0.0159; Figure S1B).
4.4 Enlargement of collecting lymphatic vessels in the
lower limb
We next aimed to determine if the functional differences in
contractility of collecting lymphatic vessels in mice on HFD versus
normal diet were associated with any morphological changes in
the collecting lymphatic vessels of the lower limb. For this
experiment, we fed C57BL/6J:ICR mice either HFD or chow for
31 weeks. We imaged the collecting lymphatic vessels of the mice
for the above parameters and found similar reductions in
contraction frequency and lack of response to mechanostimulation
(data not shown). After imaging, we sacrificed the mice and
harvested the collecting lymphatic vessels of the lower limb. We
performed whole mount immunostaining for CD31 (to visualize
the lateral saphenous vein and the accompanying collecting
lymphatic vessels and the lymphatic valves) and aSMA (to
visualize smooth muscle cell coverage) in order to determine
whether the collecting lymphatic vessel, the lymphatic valve
morphology, or the smooth muscle cell coverage were affected
[16]. We found no obvious differences in the smooth muscle cell
coverage as well as the general valve structure between the chow
and HFD collecting lymphatic vessels. Interestingly, however, the
collecting lymphatic vessels of the HFD mice appeared enlarged
(Figure 3A-F). We also evaluated non-contractile collecting
lymphatic vessels of the ear for the same parameters and observed
no apparent differences in vessel diameter, smooth muscle cell
coverage or valve morphology (Figure 3G-L).
4.5 Decreased spread of tracer in dermal lymphatic
vessels in K14-VEGF-C mice after HFD
K14-VEGF-C mice have an expanded dermal lymphatic vessel
network and display an increased spreading of tracers through
these vessels from an intradermal injection site (Figure S2)
[13,17,18]. These mice also have enlarged collecting lymphatic
vessels in the skin compared to wildtype mice (data not shown). We
hypothesized that HFD-induced expansion of subcutaneous
adipose tissue may alter the spread of the lymphatic tracer in
the initial dermal lymphatic vessels of K14-VEGF-C mice. Similar
to the results in wild-type mice, we found irregular collecting
lymphatic vessel contraction frequencies in K14-VEGF-C mice on
HFD (Figure 4A-C), with a significant inverse correlation between
the frequency of lymphatic contractions and body weight
(r2 = 0.75, P = 0.0053). K14-VEGF-C mice under chow diet
exhibited a pronounced spread of the lymphatic tracer throughout
the expanded dermal lymphatic vessels (Figure 4D and Video S3).
In contrast, the spread of the tracer was reduced under HFD
conditions (Figure 4E and Video S4), resulting in a significant
difference in skin area that is perfused with tracer in dermal
lymphatic vessels between chow and HFD-fed mice (chow:
62.1625.7% vs. HFD: 8.568.0%, P = 0.0286; Figure 4F).
Figure 3. Whole mount analysis revealed enlarged collecting
lymphatic vessels of the hind limb. CD31 (A, green) and aSMA (B,
red) stainings of collecting lymphatic vessels from chow diet fed mice
were compared to CD31 (D) and aSMA (E) stainings of collecting
lymphatic vessels from HFD fed mice. The collecting lymphatic vessels
were observed to be enlarged in the HFD fed mice. CD31 (G, green) and
aSMA (H, red) stainings of non-contractile ear collecting lymphatic
vessels from chow diet fed mice were compared to CD31 (J, green) and
aSMA (K, red) stainings from HFD fed mice. No major differences were
observed. Merged channels are shown in (C, F, I and L). Scale bars =
50 mm.
doi:10.1371/journal.pone.0094713.g003
Obesity Induces Lymphatic Dysfunction
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Discussion
The present study reveals morphological and functional changes
of collecting lymphatic vessels in extremities of obese mice. With
NIR lymphatic imaging of collecting lymphatic vessels, we found a
decreased frequency of contractions and reduced response to
mechanostimulation in three different mouse strains fed HFD.
Morphologically, contractile collecting lymphatic vessels of the
hind limb appeared larger in mice fed HFD compared to chow fed
mice. In conjunction with our findings of reduced spread of tracers
in dermal lymphatic vessels in HFD-fed K14-VEGF-C mice, these
findings suggest that an increased subcutaneous adipose tissue
expansion in response to HFD may be detrimental to lymphatic
transport. These findings are in agreement with the recent report
of reduced lymphatic transport in mice fed high-fat diet using
PET-CT imaging techniques [10]. Our results indicate that this
reduced transport capacity may be in part due to effects on the
collecting lymphatic vessels, in addition to structural changes
within draining lymph nodes suggested in a previous study [10].
Dilated collecting lymphatic vessels with a reduction in the
frequency of contractions have been found in experimental models
of inflammation and cancer [15,19]. Similar to our current
findings, a reduction in the contraction frequencies of the
mesenteric collecting lymphatic vessels was found in a rat model
of metabolic syndrome [20]. Since it is well established that obesity
is associated with low-level inflammation, there may be direct
effects of inflammatory cytokines on lymphatic vessels during
obesity [10,21]. Functionally, collecting lymphatic vessels under
HFD conditions exhibited a decreased frequency of contractions
and a diminished response to mechanostimulation. Given that
lymphangions, the contractile units of collecting lymphatic vessels,
function similar to heart ventricles [22], we assume that decreases
in regularity and frequency of contractions could result in reduced
lymphatic flow, as has been found in humans with lipedema [23]
and in obese mice [10]. Supporting this conclusion, a decreased
response to mechanostimulation of the injection site indicates a
diminished tracer perfusion into the collecting lymphatic vessels,
implying a higher resistance to flow inside the collecting lymphatic
vessel similar to the changes suggested for veins in obese patients
[24].
A typical consequence of impaired or obstructed lymphatic flow
is dermal backflow, which describes the retrograde flow of injected
dye from the collecting lymphatic vessels into the initial dermal
lymphatic vessels due to high intravascular pressure and valve
deficiency [15,25]. Despite signs of collecting lymphatic vessel
dysfunction, dermal backflow or collateral rerouting were not
observed after 17 weeks of HFD. Our finding of reduced water
content in the skin tissue is also not supportive of the development
Figure 4. Impaired collecting lymphatic vessel function and reduced spread of tracer in dermal lymphatic vessels after 17 weeks of
HFD in K14-VEGF-C mice. NIR-imaging was performed after intradermal injection of 5 mL of 25 mM P20D680. Normal (A) and irregular (B)
contraction patterns in chow and HFD mice, respectively. Linear regression analysis (C) shows a significant negative correlation between weight and
contraction frequencies. High (D) and low (E) spreading of tracer within dermal lymphatic vessels in chow and HFD fed mice, respectively, after 15
minutes of imaging. Scale bars = 2 mm. Quantification (F) shows lower percentage of tracer-perfused lymphatic vessels of the skin in the lower limb
of mice on HFD as compared to chow diet. *P#0.05.
doi:10.1371/journal.pone.0094713.g004
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of lymphedema at this time point, unlike the findings in
hypercholesterolemic mice where paw swelling was present [26].
When we performed imaging in K14-VEGF-C transgenic mice,
which show dramatic dermal lymphatic vessel expansion and
rapid spreading of lymphatic tracers after intradermal injection,
we found decreased dermal lymphatic vessel spreading under
HFD conditions. These findings suggest a model that expanded
subcutaneous fat and reduced skin water content may have
detrimental consequences for lymphatic transport through eleva-
tion of the tissue pressure in the dermis and/or diminished
hydraulic conductivity of the flow within dermal lymphatic vessel
[9]. Further studies are necessary to evaluate this hypothesis. It will
also be of interest to investigate whether the impairment of
lymphatic vascular function might be reversible after a reduction
of the calorie intake.
Supporting Information
Figure S1 Impaired collecting lymphatic vessels func-
tion after 17 weeks of HFD in C57BL/6J:ICR mice. NIR
imaging was performed after intradermal injection of 5 mL of
25 mM P40D680, a tracer specific for uptake into lymphatic
vessels. (A) Normal and irregular contraction patterns in chow
(n = 5) and HFD (n = 5) mice, respectively. Linear regression
analysis shows a significant negative correlation between weight
and contraction frequencies. (B) Normal and impaired response to
mechanostimulation. Videos were initiated 15 s after mechan-
ostimulation. Mice on HFD showed reduced response to
mechanostimulation as compared to mice on chow diet. **P#0.01
(TIF)
Figure S2 Spread of tracers in dermal lymphatic vessels
in K14-VEGF-C mice. NIR imaging was performed after
intradermal injection of 5 mL of 25 mM P20D680 in K14-VEGF-
C mice. Due to hyperplasia of dermal lymphatic vessels in this
mouse strain, the tracer spreads throughout this superficial
network of vessels rather than draining predominantly into deeper
collecting lymphatic vessels. Representative mouse 5 minutes after
injection (A) and 10 minutes after injection (B). Higher
magnification (C) demonstrates that the tracer is contained within
dermal lymphatic vessels.
(TIF)
Video S1 NIR lymphatic imaging of afferent collecting
lymphatic vessels draining into the popliteal LN in a
FVB mouse after 17 weeks of chow diet. Imaging was
performed after injection of P20D680 (5 mL of 25 mM) into dorsal
foot skin and uptake into collecting lymphatic vessels was
observed. Video is 10x normal speed and was acquired with
Cy5 filter set at 1 frame/s.
(MOV)
Video S2 NIR lymphatic imaging of afferent collecting
lymphatic vessels draining into the popliteal LN in a
FVB mouse after 17 weeks of HFD. Imaging was performed
after injection of P20D680 (5 mL of 25 mM) into dorsal foot skin
and uptake into collecting lymphatic vessels was observed. Video is
10x normal speed and was acquired with Cy5 filter set at 1
frame/s.
(MOV)
Video S3 NIR imaging of lymphatic vessels in the lower
limb in a K14-VEGF-C mouse after 17 weeks of chow
diet. Imaging was initiated 30 s after injection of P20D680 (5 mL
of 25 mM) into dorsal foot skin. Spreading of the lymphatic tracer
within dermal lymphatic vessels was seen. Video is 10x normal
speed and was acquired with Cy5 filter set at 1 frame/s.
(MOV)
Video S4 NIR imaging of lymphatic vessels draining in
the lower limb in a K14-VEGF-C mouse after 17 weeks of
HFD. Imaging was initiated 30s after injection of P20D680 (5 mL
of 25 mM) into dorsal foot skin. No spreading of the lymphatic
tracer within dermal lymphatic vessels was seen. Video is 10x
normal speed and was acquired with Cy5 filter set at 1 frame/s.
(MOV)
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